Comparison of the construct validity and reproducibility of four different types of patient-reported outcome measures (PROMs) in patients with rheumatoid arthritis by Renskers, Lisanne, van Uden, Ron J. J. C., Huis, Anita M. P., Rongen, Sanne A. A., Teerenstra, Steven, van Riel, Piet L. C. M.

Get full text

Adalimumab drug and antidrug antibody levels do not predict flare risk after stopping adalimumab in RA patients with low disease activity by Lamers-Karnebeek, Femke B G, Jacobs, Johannes W G, Radstake, Timothy R D J, van Riel, Piet L C M, Jansen, Tim L

Get full text

Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumato... by Weijers, Julia M., Semb, Anne G., Rollefstad, Silvia, Kitas, George D., van Riel, Piet L. C. M.

Get full text

Outcome measures in inflammatory rheumatic diseases by Fransen, Jaap, van Riel, Piet L C M

Get full text

Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis by Toonen, Erik J M, Gilissen, Christian, Franke, Barbara, Kievit, Wietske, Eijsbouts, Agnes M, den Broeder, Alfons A, van Reijmersdal, Simon V, Veltman, Joris A, Scheffer, Hans, Radstake, Timothy R D J, van Riel, Piet L C M, Barrera, Pilar, Coenen, Marieke J H

Get full text

Time to achieve remission determines time to be in remission by Schipper, Lydia G, Fransen, Jaap, den Broeder, Alfons A, Van Riel, Piet L C M

Get full text

The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry by DE PUNDER, Yvonne M. R, FRANSEN, Jaap, KIEVIT, Wietske, HOUTMAN, Pieternella M, VISSER, Henk, VAN DE LAAR, Mart A. F. J, VAN RIEL, Piet L. C. M

Get full text

Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis by Popa, Calin, van den Hoogen, Frank H J, Radstake, Timothy R D J, Netea, Mihai G, Eijsbouts, Agnes E, Heijer, Martin den, van der Meer, Jos W M, van Riel, Piet L C M, Stalenhoef, Anton F H, Barrera, Pilar

Get full text

Calibration of the PROMIS physical function item bank in Dutch patients with rheumatoid arthritis by Oude Voshaar, Martijn A H, ten Klooster, Peter M, Glas, Cees A W, Vonkeman, Harald E, Taal, Erik, Krishnan, Eswar, Moens, Hein J Bernelot, Boers, Maarten, Terwee, Caroline B, van Riel, Piet L C M, van de Laar, Mart A F J

Get full text

The influence of patient perceptions of disease on medication intensification in daily practice by Hendrikx, Jos, Kievit, Wietske, Fransen, Jaap, van Riel, Piet L C M

Get full text

Are patients' judgments of health status really different from the general population? by Krabbe, Paul Fm, Tromp, Noor, Ruers, Theo Jm, van Riel, Piet Lcm

Get full text

Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change by Hendrikx, Jos, Fransen, Jaap, Kievit, Wietske, van Riel, Piet L. C. M.

Get full text

The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion by VERMEER, Marloes, KUPER, Hillechiena H, VAN DER BIJL, Arie E, BAAN, Henriette, POSTHUMUS, Marcel D, BRUS, Herman L. M, VAN RIEL, Piet L. C. M, VAN DE LAAR, Mart A. F. J

Get full text

Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients’ Burden of Disease by Ghiti Moghadam, Marjan, Klooster, Peter M., Vonkeman, Harald E., Kneepkens, Eva L., Klaasen, Ruth, Stolk, Jan N., Tchetverikov, Ilja, Vreugdenhil, Simone A., Woerkom, Jan M., Goekoop‐Ruiterman, Yvonne P. M., Landewé, Robert B. M., Riel, Piet L. C. M., Laar, Mart A. F. J., Jansen, Tim L.

Get full text

Cost‐Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis by Kievit, Wietske, Maurits, Jake S. F., Arts, Elke E., van Riel, Piet L. C. M., Fransen, Jaap, Popa, Calin D.

Get full text

Patients with Systemic Sclerosis/polymyositis Overlap Have a Worse Survival Rate Than Patients Without It by Bhansing, Kavish J, van Riel, Piet L C M, van Engelen, Baziel G M, Fransen, Jaap, Vonk, Madelon C

Get full text

An Economic Evaluation of Stopping Versus Continuing Tumor Necrosis Factor Inhibitor Treatment in Rheumatoid Arthritis Patients With Disease Remission or Low Disease Activity: Resu... by Tran-Duy, An, Ghiti Moghadam, Marjan, Oude Voshaar, Martijn A H, Vonkeman, Harald E, Boonen, Annelies, Clarke, Philip, McColl, Geoff, Ten Klooster, Peter M, Zijlstra, T R, Lems, Willem F, Riyazi, N, Griep, E N, Hazes, J M W, Landewé, Robert, Bernelot Moens, Hein J, van Riel, Piet L C M, van de Laar, Mart A F J, Jansen, T L

Get full text

Circulating Leptin and Adiponectin Concentrations During Tumor Necrosis Factor Blockade in Patients with Active Rheumatoid Arthritis by POPA, Calin, NETEA, Mihai G, DE GRAAF, Jacqueline, VAN DEN HOOGEN, Frank H. J, RADSTAKE, Timothy R. D. J, TOENHAKE-DIJKSTRA, Helga, VAN RIEL, Piet L. C. M, VAN DER MEER, Jos W. M, STALENHOEF, Anton F. H, BARRERA, Pilar

Get full text

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial by Lamers-Karnebeek, Femke B G, Luime, Jolanda J, Jansen, Tim L, van Riel, Piet L C M, Jacobs, Johannes W G

Get full text